MedPath

Mobile Applications to Reduce Risk of Stroke

Completed
Conditions
Stroke
Public Health - Health promotion/education
Stroke - Haemorrhagic
Stroke - Ischaemic
Registration Number
ACTRN12616000376448
Lead Sponsor
Prof Valery Feigin
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
50
Inclusion Criteria

(1) those screened with by their GP with at least 2 modifiable stroke risk factors identified; (2) those who own a Smartphone; (3) those who give informed consent to participate in the study.

Exclusion Criteria

previous history of stroke, diagnosis of life-threatening conditions (as determined by GP), significant cognitive impairment or other conditions deemed unsuitable by their GP to participate in this research (e.g., psychiatric disorders, alcoholism).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change from baseline in awareness about stroke risk and associated stroke risk factors. Participants will be asked to identify stroke symptoms and risk factors - and the percentage change in correct responses will be calculated. [6 months post baseline]
Secondary Outcome Measures
NameTimeMethod
Change from baseline in stroke risk. Participants complete the Stroke Riskometer questionnaire to measure their absolute 5 and 10 year stroke risk, and any change in the risk between baseline and follow-ups are measured. [6 months post baseline];Change in health behaviours related to stroke risk factors. Changes in the Life's Simple 7 health behaviour score are recorded to determine change in behaviour related to modifiable risk factors associated with stroke. [6 months post baseline];Determine feasibility of a full-scale RCT using the same intervention. A semi-structured qualitative interview will be used to ask participants about the acceptability of the intervention. This, in addition to the findings of the pilot trial will be used to inform the feasibility of conducting a full scale trial to investigate the efficacy of the Stroke Riskometer app as tool for primary stroke prevention[6 months post baseline]
© Copyright 2025. All Rights Reserved by MedPath